Abbott Increases Quarterly Dividend, Marking 51 Consecutive Years of Dividend Growth Pharmaceutical Investing
Kite and Arcellx Announce Strategic Collaboration to Co-develop and Co-commercialize Late-stage Clinical CART-ddBCMA in Multiple Myeloma Pharmaceutical Investing
Arcellx and Kite Announce Strategic Collaboration to Co-Develop and Co-Commercialize Late-Stage Clinical CART-ddBCMA in Multiple Myeloma Pharmaceutical Investing
Erasca Announces Exclusive Worldwide License for Pan-RAF Inhibitor Naporafenib Pharmaceutical Investing
Pfizer and BioNTech Receive U.S. FDA Emergency Use Authorization for Omicron BA.4/BA.5-Adapted Bivalent COVID-19 Vaccine in Children Under 5 Years Pharmaceutical Investing
Gilead Sciences: U.S. Military Veteran Battles Lymphoma With Car T-Cell Therapy: Marcus' Story Pharmaceutical Investing
BriaCell Announces Positive Clinical and Quality of Life Data in Advanced Metastatic Breast Cancer at 2022 San Antonio Breast Cancer Symposium® Pharmaceutical Investing
Kite and Daiichi Sankyo Announce Changes to YESCARTA® CAR T-Cell Therapy Licensing Agreement in Japan Pharmaceutical Investing
Johnson & Johnson to Participate in the 41st Annual J.P. Morgan Healthcare Conference Pharmaceutical Investing
U.S. FDA Accepts for Priority Review the Biologics License Application for Pfizer's Respiratory Syncytial Virus Vaccine Candidate for the Prevention of RSV Disease in Older Adults Pharmaceutical Investing
